Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
/in Colorectal Cancer, International Publications, NSCLC /von 2005-07-21 / Cancer Immunol. Immunother. 2006 Mar;55(3):268-76Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
/in International Publications, Malignant Lymphoma /von 2005-07-15 / Cancer Immunol. Immunother. 2006 Apr;55(4):420-32Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
/in Colorectal Cancer, International Publications /von 2005-07-15 / J. Immunol. 2005 Jul;175(2):820-8Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings
/in Colorectal Cancer, International Publications /von 2005-07-07 / Oncology 2005;68(2-3):276-84Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
/in International Publications, Malignant Lymphoma /von 2005-07-01 / Cancer Res. 2005 Jul;65(13):5958-64Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy
/in International Publications, Malignant Lymphoma /von 2005-07-01 / J. Immunother. 2005 Jul-Aug;28(4):322-31Chemosensitization of pancreatic carcinoma cells to enhance T cell-mediated cytotoxicity induced by tumor lysate-pulsed dendritic cells
/in International Publications, Pancreatic Cancer /von 2005-07-01 / J. Immunother. 2005 Jul-Aug;28(4):332-42Active immunotherapy for advanced intracranial murine tumors by using dendritic cell-tumor cell fusion vaccines
/in Glioblastoma, International Publications /von 2005-07-01 / J. Neurosurg. 2005 Jul;103(1):156-64Human papillomavirus L1L2-E7 virus-like particles partially mature human dendritic cells and elicit E7-specific T-helper responses from patients with cervical intraepithelial neoplasia or cervical cancer in vitro
/in Cervical Cancer, International Publications /von 2005-07-01 / Hum. Immunol. 2005 Jul;66(7):762-72
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution